Viking Therapeutics EPS - Earnings per Share 2014-2024 | VKTX

Viking Therapeutics earnings per share (EPS) for the twelve months ending September 30, 2024 was $-0.92, a 0% increase year-over-year.

  • Viking Therapeutics EPS for the quarter ending September 30, 2024 was $-0.22, a 4.35% decline year-over-year.
  • Viking Therapeutics 2023 annual EPS was $-0.91, a 1.11% increase from 2022.
  • Viking Therapeutics 2022 annual EPS was $-0.9, a 26.76% increase from 2021.
  • Viking Therapeutics 2021 annual EPS was $-0.71, a 31.48% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Viking Therapeutics EPS - Earnings per Share 2014-2024 | VKTX

  • Viking Therapeutics EPS for the quarter ending September 30, 2024 was $-0.22, a 4.35% decline year-over-year.
  • Viking Therapeutics 2023 annual EPS was $-0.91, a 1.11% increase from 2022.
  • Viking Therapeutics 2022 annual EPS was $-0.9, a 26.76% increase from 2021.
  • Viking Therapeutics 2021 annual EPS was $-0.71, a 31.48% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.